- Filed
- May 11, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 30, 2026 | 90.91M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 85.63M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 84.37M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $259K |
| Capex | Q1 2026 · Mar 31, 2025 | $1.03M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$19.34M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$5.62M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $95.97M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $115.51M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $168.07M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $183.95M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $102.36M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $98.67M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $267.14M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $261.13M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $151.17M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $161.3M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $435.21M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $444.41M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.19 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.19 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $23.19M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $27.33M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$16.28M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$5.99M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$17.51M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$5.35M |
| Revenue | Q1 2026 · Mar 31, 2026 | $214.33M |
| Revenue | Q1 2026 · Mar 31, 2025 | $253.4M |